ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,633,412 | -14.3% | 174,348 | -1.5% | 0.27% | -8.3% |
Q2 2023 | $4,240,635 | +126827.1% | 177,062 | -0.3% | 0.29% | +21.8% |
Q1 2023 | $3,341 | +19.4% | 177,523 | +1.0% | 0.24% | +24.0% |
Q4 2022 | $2,799 | -99.9% | 175,841 | -1.1% | 0.19% | -13.1% |
Q3 2022 | $2,910,000 | +20.1% | 177,852 | +3.4% | 0.22% | +26.3% |
Q2 2022 | $2,422,000 | -40.7% | 171,922 | +2.0% | 0.18% | -33.2% |
Q1 2022 | $4,084,000 | +4.0% | 168,621 | +0.2% | 0.26% | +9.6% |
Q4 2021 | $3,928,000 | +40.8% | 168,276 | +0.2% | 0.24% | +30.6% |
Q3 2021 | $2,790,000 | -31.1% | 167,953 | +1.2% | 0.18% | -29.6% |
Q2 2021 | $4,048,000 | -2.4% | 165,965 | +3.2% | 0.26% | -8.8% |
Q1 2021 | $4,149,000 | +46.3% | 160,818 | +203.2% | 0.28% | +42.5% |
Q4 2020 | $2,836,000 | +125.3% | 53,046 | +73.8% | 0.20% | +98.0% |
Q3 2020 | $1,259,000 | – | 30,526 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |